Elsevier

Neurobiology of Disease

Volume 7, Issue 6, December 2000, Pages 657-665
Neurobiology of Disease

Regular Article
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors

https://doi.org/10.1006/nbdi.2000.0311Get rights and content

Abstract

Serum levels of insulin and insulin-like growth factors and their binding proteins (IGFs and IGFBPs, respectively) are changed in human neurodegenerative diseases of very different etiology, such as Alzheimer's disease, amyotrophic lateral sclerosis, or cerebellar ataxia. However, the significance of these endocrine disturbances is not clear. We now report that in two very different inherited neurodegenerative conditions, ataxia-telangiectasia (AT) and Charcot-Marie-Tooth 1A (CMT-1A) disease, serum levels of IGFs are also altered. Both types of patients have increased serum IGF-I and IGFBP-2 levels, and decreased serum IGFBP-1 levels, while only AT patients have high serum insulin levels. Furthermore, serum IGFs are also changed in three different animal models of neurodegeneration: neurotoxin-induced motor discoordination, diabetic neuropathy, and hereditary cerebellar ataxia. In these three models, serum insulin levels are significantly decreased, serum IGF-I and IGFBP-1, -2, and -3 are decreased in diabetic and neurotoxin-injected rats, while serum IGFBP-1 is increased in hereditary ataxic rats. Altogether, these observations indicate that a great variety of neurodegenerative diseases show endocrine perturbations, resulting in changes in serum IGFs levels. These perturbations are disease-specific and are probably due to metabolic and endocrine derangements, nerve cell death, and sickness-related disturbances associated to the neurodegenerative process. Our observations strongly support the need to evaluate serum IGFs in other neurodegenerative conditions.

References (53)

  • L.W. Wolf et al.

    A behavioral study of the development of hereditary ataxia in the shaker mutant rat

    Behav. Brain Res.

    (1996)
  • W. Zhang et al.

    Decreased IGF gene expression during the apoptosis of Purkinje cells in pcd mice

    Dev. Brain Res.

    (1997)
  • M.A.I Aberg et al.

    Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus

    J. Neurosci.

    (2000)
  • C.S. Armstrong et al.

    Uptake of circulating insulin-like growth factor I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rats

    J. Neurosci. Res.

    (2000)
  • G.J. Biessels et al.

    Cerebral function in diabetes mellitus

    Diabetologia

    (1994)
  • S. Busiguina et al.

    Specific alterations of the insulin like growth factor I system in the cerebellum of diabetic rats

    Endocrinology

    (1996)
  • E. Carro et al.

    Circulating insulin-like growth factor I mediates effects of exercise on the brain

    J. Neurosci.

    (2000)
  • S. Craft et al.

    Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype

    Neurology

    (1998)
  • S. Doré et al.

    Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases

    Trends Neurosci.

    (1997)
  • J. Fan et al.

    Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin 1

    Am. J. Physiol.

    (1998)
  • A.M. Fernandez et al.

    Insulin-like growth factor-I modulates c-Fos induction and astrocytosis in response to neurotoxic insult

    Neuroscience

    (1997)
  • A.M. Fernandez et al.

    Insulin-like growth factor restores motor coordination in a rat model of cerebellar ataxia

    Proc. Natl. Acad. Sci. USA

    (1998)
  • A.M. Fernandez et al.

    Neuroprotective actions of peripherally administered insulin-like growth factor I on the injured olivo-cerebellar pathway

    Eur. J. Neurosci.

    (1999)
  • R.J Ferry et al.

    Cellular actions of insulin-like growth factor binding proteins

    Horm. Metab. Res.

    (1999)
  • R.A. Frost et al.

    Growth factors in critical illness: Regulation and therapeutic aspects

    Curr. Opin. Clin. Nutr. Metab. Care

    (1998)
  • A. Garcia et al.

    Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: A longitudinal clinical and electrophysiological study

    Neurology

    (1998)
  • Cited by (112)

    • Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. Analysis of sex differences

      2019, Frontiers in Neuroendocrinology
      Citation Excerpt :

      In addition, aging and brain pathology may also affect other components of estrogen neuroprotective signaling. For instance, plasma levels of IGF-1, which as we have discussed in this paper is a factor interacting with estradiol neuroprotective signaling, are decreased with aging and are altered under different neurological conditions in humans (Busiguina et al., 2000). In addition, a dissociation of the molecular interactions of ERs and IGF-1 receptors in caveolae has been detected in the brain of AD patients, suggesting an altered estradiol signaling in this pathology (Canerina-Amaro et al., 2017).

    View all citing articles on Scopus
    View full text